Involvement of Staphylococcus aureus in erysipelas

Dermatology

Volumn 212, Issue 1, 2005, Pages 1-3

  Denis, O ^a   Simonart, T ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Lactams; Cellulitis; Erysipelas; Methicillin; Staphylococcus aureus

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; LINCOSAMINE DERIVATIVE; MACROLIDE; MEMBRANE PROTEIN; METICILLIN; PENICILLIN BINDING PROTEIN; PENICILLIN G; PENICILLINASE; QUINOLONE DERIVATIVE; SODIUM CHLORIDE; STREPTOGRAMIN DERIVATIVE; VIRULENCE FACTOR;

ABSCESS; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BIOPSY; BLISTER; BLOOD CULTURE; CELLULITIS; CLINICAL TRIAL; CROSS RESISTANCE; DERMIS; DRUG SENSITIVITY; EDEMA; EDITORIAL; ERYSIPELAS; ERYTHEMA; GRAM STAINING; HOSPITALIZATION; HUMAN; IMMUNOFLUORESCENCE; INFECTION; NEEDLE BIOPSY; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; SKIN BIOPSY; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES; SUBCUTANEOUS TISSUE;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; ERYSIPELAS; HUMANS; METHICILLIN; METHICILLIN RESISTANCE; SKIN; STAPHYLOCOCCUS; TREATMENT OUTCOME;

EID: 28844451103     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089013     Document Type: Editorial

References (22)

1. Guberman D, Gilead LT, Zlotogorski A, Schamroth J: Bullous erysipelas: a retrospective study of 26 patients. J Am Acad Dermatol 1999;41:733-737.
2. Musette P, Benichou J, Noblesse I, Hellot MF, Carvalho P, Young P, Levesque H, Courtois H, Caron F, Lauret P, Joly P: Determinants of severity for superficial cellutitis (erysipelas) of the leg: a retrospective study. Eur J Intern Med 2004;15:446-450.
3. Krasagakis K, Samonis G, Maniatakis P, Georgala S, Tosca A: Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance. Dermatology 2006;212:31-35.
4. Bisno AL, Stevens DL: Streptococcal infections of skin and soft tissues. N Engl J Med 1996;334:240-245.
5. Société Française de Dermatologie: Erysipèle et fasciite nécrosante: prise en charge. Ann Dermatol Venereol 2001;128:463-482.
6. Bernard P, Bedane C, Mounier M, Denis F, Catanzano G, Bonnetblanc JM: Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol 1989;125:779-782.
7. Hook EW 3rd, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M: Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med 1986;146:295-297.
8. Duvanel T, Auckenthaler R, Rohner P, Harms M, Saurat JH: Quantitative cultures of biopsy specimens from cutaneous cellulitis. Arch Intern Med 1989;149:293-296.
9. Sachs MK: The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults. Arch Intern Med 1990;150:1907-1912.
10. Perl B, Gottehrer NP, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM: Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis 1999;29:1483-1488.
11. Foster TJ: The Staphylococcus aureus 'superbug'. J Clin Invest 2004;114:1693-1696.
12. Jorup-Ronstrom C: Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis 1986;18:519-524.
13. Eriksson B, Jorup-Ronstrom C, Karkkonen K, Sjoblom AC, Holm SE: Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis 1996;23:1091-1098.
14. Leppard BJ, Seal DV, Colman G, Hallas G: The value of bacteriology and serology in the diagnosis of erysipelas. Br J Dermatol 1985;112:559-567.
15. Bernard P, Plantin P, Roger H, Sassolas B, Villaret E, Legrain V, Roujeau JC, Rezvani Y, Scheimberg A: Roxithromycin versus penicillin in the treatment of erysipelas in adults: a comparative study. Br J Dermatol 1992;127:155-159.
16. Brogden KA, Guthmiller JM, Taylor CE: Human polymicrobial infections. Lancet 2005;365:253-255.
17. Lindsay JA, Holden MT: Staphylococcus aureus: superbug, super genome? Trends Microbiol 2004;12:378-385.
18. Denis O, Deplano A, Nonhoff C, De Ryck R, de Mendonca R, Rottiers S, Vanhoof R, Struelens MJ: National surveillance of methicillin-resistant Staphylococcus aureus in Belgian hospitals indicates rapid diversification of epidemic clones. Antimicrob Agents Chemother 2004;48:3625-3629.
19. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J: Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003;9:978-984.
20. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, Vandenesch F, Fridkin S, O'Boyle C, Danila RN, Lynfield R: Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-2984.
21. Cohen PR, Kurzrock R: Community-acquired methicillin-resistant Staphylococcus aureus skin infections: an emerging clinical problem. J Am Acad Dermatol 2004;50:277-280.
22. Eady EA, Cove JH: Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 2003;16:103-124.